Cargando…
Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke
BACKGROUND: It is sometimes difficult to choose anti-thrombotic agents for secondary prevention in stroke patients at high bleeding risk. Recently, Eicosapentaenoic Acid (EPA) was reported to reduce the recurrence of stroke in hypercholesterolemic patients without increasing hemorrhagic risk. In thi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471066/ https://www.ncbi.nlm.nih.gov/pubmed/26084813 http://dx.doi.org/10.1186/s40169-015-0062-5 |